xLabel	specimenDescriptorFill	boxSampleCount	geneEnsemblId	geneSymbol	pmtl	dataset	disease	gtexTissueSubgroup	efo	mondo	gtexTissueSubgroupUberon	tpmMean	tpmSd	tpmMin	tpm25thPercentile	tpmMedian	tpm75thPercentile	tpmMax
Acute Lymphoblastic Leukemia  (Dataset = TARGET, Specimen = Pediatric Primary Tumors, N = 538)	Pediatric Primary Tumors	538	ENSG00000097007	ABL1	Relevant Molecular Target (PMTL version 3.1)	TARGET	Acute Lymphoblastic Leukemia		EFO_0000220	MONDO_0004967		15.95	15.26	0	5.58	9.36	21.86	101.57
Acute Myeloid Leukemia  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 147)	TCGA Primary Tumors	147	ENSG00000097007	ABL1	Relevant Molecular Target (PMTL version 3.1)	TCGA	Acute Myeloid Leukemia		EFO_0000222	MONDO_0018874		51.95	19.47	18.75	38.48	48.41	62.55	107.21
Adrenocortical Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 77)	TCGA Primary Tumors	77	ENSG00000097007	ABL1	Relevant Molecular Target (PMTL version 3.1)	TCGA	Adrenocortical Carcinoma		EFO_1000796	MONDO_0006639		46.64	25.76	3.75	28.35	43.41	65.86	141.21
Bladder Urothelial Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 405)	TCGA Primary Tumors	405	ENSG00000097007	ABL1	Relevant Molecular Target (PMTL version 3.1)	TCGA	Bladder Urothelial Carcinoma		EFO_0006544	MONDO_0005611		38.28	19.65	3.89	23.64	35.8	49.38	130.18
Breast Invasive Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 1088)	TCGA Primary Tumors	1088	ENSG00000097007	ABL1	Relevant Molecular Target (PMTL version 3.1)	TCGA	Breast Invasive Carcinoma		EFO_1000307	MONDO_0006256		57.23	22.45	9.83	40.91	56.4	70.8	163.66
Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 304)	TCGA Primary Tumors	304	ENSG00000097007	ABL1	Relevant Molecular Target (PMTL version 3.1)	TCGA	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma		EFO_1000162	MONDO_0006143		41.28	20.2	1.96	29.59	38.57	49.25	172.32
Cholangiocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 35)	TCGA Primary Tumors	35	ENSG00000097007	ABL1	Relevant Molecular Target (PMTL version 3.1)	TCGA	Cholangiocarcinoma		EFO_0005221	MONDO_0019087		40.04	17.01	13.98	27.62	38.9	52.41	82.35
Chromophobe renal cell carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 65)	TCGA Primary Tumors	65	ENSG00000097007	ABL1	Relevant Molecular Target (PMTL version 3.1)	TCGA	Chromophobe renal cell carcinoma		EFO_0000335	MONDO_0017885		34.67	20.34	6.89	21.2	31.27	42.11	117.93
Colon Adenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 288)	TCGA Primary Tumors	288	ENSG00000097007	ABL1	Relevant Molecular Target (PMTL version 3.1)	TCGA	Colon Adenocarcinoma		EFO_1001949	MONDO_0002271		58.69	20.32	6.53	43.54	58.7	73.84	129.58
Cutaneous Melanoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 102)	TCGA Primary Tumors	102	ENSG00000097007	ABL1	Relevant Molecular Target (PMTL version 3.1)	TCGA	Cutaneous Melanoma		EFO_0000389	MONDO_0005012		62.54	35.38	9.95	36.48	53.36	82.71	157.77
Esophageal Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 158)	TCGA Primary Tumors	158	ENSG00000097007	ABL1	Relevant Molecular Target (PMTL version 3.1)	TCGA	Esophageal Carcinoma		EFO_0002916	MONDO_0019086		65.02	28.9	18.1	47.4	58.32	78.6	237.32
Glioblastoma Multiforme  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 152)	TCGA Primary Tumors	152	ENSG00000097007	ABL1	Relevant Molecular Target (PMTL version 3.1)	TCGA	Glioblastoma Multiforme		EFO_0000519	MONDO_0018177		69.84	33.48	10.58	48.44	67.63	87.93	219.37
Head and Neck Squamous Cell Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 498)	TCGA Primary Tumors	498	ENSG00000097007	ABL1	Relevant Molecular Target (PMTL version 3.1)	TCGA	Head and Neck Squamous Cell Carcinoma		EFO_0000181	MONDO_0010150		46.47	22.17	2.81	30.41	44.36	59.82	122.58
Hepatocellular Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 369)	TCGA Primary Tumors	369	ENSG00000097007	ABL1	Relevant Molecular Target (PMTL version 3.1)	TCGA	Hepatocellular Carcinoma		EFO_0000182	MONDO_0007256		18.01	12.73	1.48	10.18	14.31	21.35	82.75
Low-grade glioma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 507)	TCGA Primary Tumors	507	ENSG00000097007	ABL1	Relevant Molecular Target (PMTL version 3.1)	TCGA	Low-grade glioma		MONDO_0021637	MONDO_0021637		83.62	30.64	18.68	61.61	80.62	103.33	232.13
Lung Adenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 510)	TCGA Primary Tumors	510	ENSG00000097007	ABL1	Relevant Molecular Target (PMTL version 3.1)	TCGA	Lung Adenocarcinoma		EFO_0000571	MONDO_0005061		46.25	20.38	6.02	32.96	43.61	56.93	161.47
Lung Squamous Cell Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 498)	TCGA Primary Tumors	498	ENSG00000097007	ABL1	Relevant Molecular Target (PMTL version 3.1)	TCGA	Lung Squamous Cell Carcinoma		EFO_0000708	MONDO_0005097		45.61	20.7	3.92	32.49	41.43	55.46	135.22
Lymphoid Neoplasm Diffuse Large B-cell Lymphoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 47)	TCGA Primary Tumors	47	ENSG00000097007	ABL1	Relevant Molecular Target (PMTL version 3.1)	TCGA	Lymphoid Neoplasm Diffuse Large B-cell Lymphoma		EFO_0000403	MONDO_0018905		28.13	18.99	5.91	11.42	27.51	40.51	91.98
Mesothelioma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 86)	TCGA Primary Tumors	86	ENSG00000097007	ABL1	Relevant Molecular Target (PMTL version 3.1)	TCGA	Mesothelioma		EFO_0000588	MONDO_0005065		66.94	30.81	18.65	44.89	61.97	83.02	186.26
Ovarian Serous Cystadenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 373)	TCGA Primary Tumors	373	ENSG00000097007	ABL1	Relevant Molecular Target (PMTL version 3.1)	TCGA	Ovarian Serous Cystadenocarcinoma		EFO_1000043	MONDO_0006046		42.17	24.75	6.51	22.99	36.2	55.23	142.81
Pancreatic Adenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 177)	TCGA Primary Tumors	177	ENSG00000097007	ABL1	Relevant Molecular Target (PMTL version 3.1)	TCGA	Pancreatic Adenocarcinoma		EFO_1000044	MONDO_0006047		50.76	21.87	5.23	35.42	49.28	62.76	137.24
Pheochromocytoma and Paraganglioma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 177)	TCGA Primary Tumors	177	ENSG00000097007	ABL1	Relevant Molecular Target (PMTL version 3.1)	TCGA	Pheochromocytoma and Paraganglioma		EFO_0020005	MONDO_0035540		35.36	13.24	10.29	25.75	34.5	41.91	90
Prostate Adenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 494)	TCGA Primary Tumors	494	ENSG00000097007	ABL1	Relevant Molecular Target (PMTL version 3.1)	TCGA	Prostate Adenocarcinoma		EFO_0000673	MONDO_0005082		65.77	23.79	12.78	50.26	65.88	80.88	165.02
Rectum Adenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 92)	TCGA Primary Tumors	92	ENSG00000097007	ABL1	Relevant Molecular Target (PMTL version 3.1)	TCGA	Rectum Adenocarcinoma		EFO_0005631	MONDO_0002169		60	21.72	9.47	45.27	58.29	71.78	134.34
Renal Clear Cell Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 527)	TCGA Primary Tumors	527	ENSG00000097007	ABL1	Relevant Molecular Target (PMTL version 3.1)	TCGA	Renal Clear Cell Carcinoma		EFO_0000349	MONDO_0005005		42.89	19.63	3.27	29	40.04	53.82	191.35
Renal Papillary Cell Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 286)	TCGA Primary Tumors	286	ENSG00000097007	ABL1	Relevant Molecular Target (PMTL version 3.1)	TCGA	Renal Papillary Cell Carcinoma		EFO_0000640	MONDO_0017884		45.11	25.35	6.39	27.3	40.08	56.67	197.15
Sarcoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 258)	TCGA Primary Tumors	258	ENSG00000097007	ABL1	Relevant Molecular Target (PMTL version 3.1)	TCGA	Sarcoma		EFO_0000691	MONDO_0005089		125.62	72.23	9.21	75.56	108.7	163.4	461.5
Stomach Adenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 373)	TCGA Primary Tumors	373	ENSG00000097007	ABL1	Relevant Molecular Target (PMTL version 3.1)	TCGA	Stomach Adenocarcinoma		EFO_0000503	MONDO_0005036		56.97	31.05	13.02	35.33	50.34	70.03	183.24
Testicular Germ Cell Tumor  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 148)	TCGA Primary Tumors	148	ENSG00000097007	ABL1	Relevant Molecular Target (PMTL version 3.1)	TCGA	Testicular Germ Cell Tumor		EFO_1000566	MONDO_0010108		64.73	34.62	9.06	38.33	55.84	86	159.04
Thymoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 118)	TCGA Primary Tumors	118	ENSG00000097007	ABL1	Relevant Molecular Target (PMTL version 3.1)	TCGA	Thymoma		EFO_1000581	MONDO_0006456		62.49	38.95	3.98	33.74	51	75.6	174.93
Thyroid Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 501)	TCGA Primary Tumors	501	ENSG00000097007	ABL1	Relevant Molecular Target (PMTL version 3.1)	TCGA	Thyroid Carcinoma		EFO_0002892	MONDO_0015075		73.97	26.73	6.38	54.15	75.16	92.04	153.32
Uterine Carcinosarcoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 56)	TCGA Primary Tumors	56	ENSG00000097007	ABL1	Relevant Molecular Target (PMTL version 3.1)	TCGA	Uterine Carcinosarcoma		EFO_1000613	MONDO_0006485		71.42	34.58	12.8	51.55	65.3	84.6	218.95
Uterine Corpus Endometrial Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 178)	TCGA Primary Tumors	178	ENSG00000097007	ABL1	Relevant Molecular Target (PMTL version 3.1)	TCGA	Uterine Corpus Endometrial Carcinoma		EFO_0007532	MONDO_0000553		47.08	26.54	2.39	29.44	43.33	62.97	153.64
Uveal Melanoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 79)	TCGA Primary Tumors	79	ENSG00000097007	ABL1	Relevant Molecular Target (PMTL version 3.1)	TCGA	Uveal Melanoma		EFO_1000616	MONDO_0006486		106.99	37.2	30.52	74	109.9	133.18	209.03